Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
21 juin 2026 mis à jour par: Ahmed Abdelnaser Mohamed Mohamed Youness, Cairo University
Effect of Transfer Energy Capacitive and Resistive on Carpal Tunnel Syndrome Post Burn
Carpal Tunnel Syndrome (CTS) is a common entrapment neuropathy that can develop as a secondary complication following deep burns involving the hand or wrist. Post-burn CTS arises due to factors such as fibrosis, edema, and scar contracture, which may increase pressure on the median nerve within the carpal tunnel, leading to significant pain, sensory disturbances, and impaired hand function Recent studies support the effectiveness of Transfer Energy Capacitive and Resistive (TECAR ) therapy in idiopathic CTS, showing improvements in pain, symptom severity, and function, as measured by validated tools such as the Boston Carpal Tunnel Questionnaire (BCTQ) and Visual Analogue Scale (VAS).
A study reported that both TECAR and ultrasound groups showed significant symptom improvement after treatment, although ultrasound had more sustained effects on median nerve cross-sectional area at 3 months
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Description détaillée
This study will involve 52 patients diagnosed with CTS post-burn; they will receive TECAR as an intervention.
The outcome measures include ( VAS, Arabic version of Boston Carpal Tunnel Questionnaire, and Camry Digital Handgrip Dynamometer
Type d'étude
Interventionnel
Inscription (Estimé)
52
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Ahmed abdelnasr Mohamed Youness, Demonstrator (TA)
- Numéro de téléphone: +2001553712231
- E-mail: pt.ahmed.mido@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Nada Mohamed Yousef, Lecturer
- Numéro de téléphone: +2001002010168
- E-mail: Dr.nada123.ny@gmail.com
Lieux d'étude
-
-
Mansoura
-
Al Mansurah, Mansoura, Egypte, 35511
- QWAM physio clinic
-
Contact:
- Mohamed Mohamed Abdelwahab, Supervisor
- Numéro de téléphone: +2001557393444
- E-mail: outlast829@gmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Participant is between 20 and 40 years of age.
- Diagnosed with mild to moderate carpal tunnel syndrome (CTS).
- History of an upper limb burn, with the percentage of the Total Body Surface Area (TBSA) ranging from 20% to 25%.
- Upper limb burn is diagnosed as a 2nd or 3rd-degree burn complicated with carpal tunnel syndrome.
- Carpal tunnel syndrome diagnosis is clinically confirmed using physical examination, including a positive Tinel's sign and positive Phalen's test.
- Participant provides written informed consent before enrollment.
Exclusion Criteria:
- History of double crush syndrome, cervical radiculopathy, or fibromyalgia.
- History of wrist fracture or distal radius fracture.
- Diagnosis of systemic or local diseases that contribute to peripheral neuropathy, including Diabetes Mellitus or rheumatoid arthritis (RA).
- Diagnosis of hypothyroidism, skin diseases, or peripheral vascular diseases.
- Current or past history of cancer.
- Use of a hand or wrist splint within the past three months.
- Presence of an implanted pacemaker or electrical prosthesis.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: The Control Group
Participants in this arm will receive standard post-burn hand rehabilitation (e.g., Exercise, stretch, and US)
|
US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises
|
|
Expérimental: The TECAR Group
Participants in this group will receive TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), three sessions per week for two weeks plus standard post-burn hand rehabilitation
|
TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), The passive electrode was fixed to the dorsum of the hand while the active electrode was moved in a circular manner from the proximal carpal tunnel to the median nerve pathway of the palm in three sessions per week for two weeks
US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Symptom Severity
Délai: Baseline and 2 weeks
|
The Arabic version of the BCTQ-SSS will be used to self-report symptom severity.
It consists of 11 items assessing pain, numbness, paresthesia, weakness, and nocturnal symptoms.
Each item is scored from 1 (never/none) to 5 (most severe).
The overall score is calculated as the mean of the items, ranging from 1 to 5, where higher scores indicate worse symptom severity.
|
Baseline and 2 weeks
|
|
Functional Status
Délai: Baseline and 2 weeks.
|
The Arabic version of the BCTQ-FSS will be used to evaluate hand function across 8 common activities.
Each activity is scored from 1 (no difficulty) to 5 (cannot perform the activity at all).
The total score is the mean of the items, ranging from 1 to 5, where higher scores represent greater functional impairment.
|
Baseline and 2 weeks.
|
|
Grip Strength
Délai: Baseline and 2 weeks.
|
Objective hand function and force production of the median nerve-innervated muscles will be measured using a Camry Digital Handgrip Dynamometer.
Measurements are recorded in kilograms (kg), up to a maximum strength of 90 kg.
Higher scores indicate greater hand grip strength.
|
Baseline and 2 weeks.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain Intensity
Délai: Baseline and 2 weeks.
|
Pain intensity will be measured using the Arabic version of the VAS, where patients mark their current pain level on a 10-cm line.
The scale ranges from 0 cm ("no pain") to 10 cm ("worst pain").
Higher scores represent greater pain severity.
|
Baseline and 2 weeks.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Directeur d'études: Wafaa Hussien Borhan, Professor, Cairo University
- Directeur d'études: Ashraf Alsibai Mohamed, Professor, Cairo University
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Chesterton LS, Blagojevic-Bucknall M, Burton C, Dziedzic KS, Davenport G, Jowett SM, Myers HL, Oppong R, Rathod-Mistry T, van der Windt DA, Hay EM, Roddy E. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet. 2018 Oct 20;392(10156):1423-1433. doi: 10.1016/S0140-6736(18)31572-1.
- Tashiro Y, Hasegawa S, Yokota Y, Nishiguchi S, Fukutani N, Shirooka H, Tasaka S, Matsushita T, Matsubara K, Nakayama Y, Sonoda T, Tsuboyama T, Aoyama T. Effect of Capacitive and Resistive electric transfer on haemoglobin saturation and tissue temperature. Int J Hyperthermia. 2017 Sep;33(6):696-702. doi: 10.1080/02656736.2017.1289252. Epub 2017 Feb 19.
- Yeste-Fabregat M, Baraja-Vegas L, Vicente-Mampel J, Perez-Bermejo M, Bautista Gonzalez IJ, Barrios C. Acute Effects of Tecar Therapy on Skin Temperature, Ankle Mobility and Hyperalgesia in Myofascial Pain Syndrome in Professional Basketball Players: A Pilot Study. Int J Environ Res Public Health. 2021 Aug 19;18(16):8756. doi: 10.3390/ijerph18168756.
- Vahdatpour, B., Ghasemi, H. R., & Taheri, P. (2023). Effectiveness of TECAR Therapy on Clinical Symptoms and Neurophysiological Parameters of Patients with Carpal Tunnel Syndrome: A Randomized Clinical Trial. Middle East Journal of Rehabilitation and Health Studies, 10(3). https://doi.org/10.5812/mejrh-134171
- Tezen O, Bilir EE, Uzun O, Yaniktas D, Senturk B, Yasar E. Evaluation of the efficacy of transfer energy capacitive and resistive therapy in patients with knee osteoarthritis. Turk J Med Sci. 2024 Oct 7;54(6):1302-1309. doi: 10.55730/1300-0144.5913. eCollection 2024.
- Tezen O, Ata AM, Uzun O, Cakir F, Yasar E. Comparison of the effectiveness of ultrasound and transfer energy capacitive and resistive (TECAR) therapy in patients with carpal tunnel syndrome. Lasers Med Sci. 2025 Mar 19;40(1):147. doi: 10.1007/s10103-025-04412-z.
- Szabo DA, Neagu N, Teodorescu S, Predescu C, Sopa IS, Panait L. TECAR Therapy Associated with High-Intensity Laser Therapy (Hilt) and Manual Therapy in the Treatment of Muscle Disorders: A Literature Review on the Theorised Effects Supporting Their Use. J Clin Med. 2022 Oct 19;11(20):6149. doi: 10.3390/jcm11206149.
- Rosario NB, De Jesus O. Electrodiagnostic Evaluation of Carpal Tunnel Syndrome. 2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK562235/
- Ribeiro, S., Henriques, B., & Cardoso, R. (2018). To cite this article Samuel Ribeiro, Bebiana Henriques, Ricardo Cardoso. The Effectiveness of Tecar Therapy in Musculoskeletal Disorders. In International Journal of Public Health and Health Systems (Vol. 3, Issue 5). http://www.openscienceonline.com/journal/ijphhs
- Niajalili M, Mohsen Roostayi M, Daryabor A, Naimi SS, Amoli MJ. The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study. Turk J Phys Med Rehabil. 2023 Oct 12;69(4):479-487. doi: 10.5606/tftrd.2023.11875. eCollection 2023 Dec.
- Mitie Ida, A., Borba Neves, E., & Wan Stadnik, A. M. (2023). Effects of Tecartherapy on Body Tissue: A Systematic Review. Journal of Biomedical Science and Engineering, 16(10), 133-148. https://doi.org/10.4236/jbise.2023.1610010
- Mahran, H. G., Mohammed, A. H., & Aboelazm, S. N. (2015). EXTRACORPOREAL SHOCKWAVE THERAPY FOR POST BURN CARPAL TUNNEL SYNDROME. International Journal of Physiotherapy and Research, 3(2), 938-946. https://doi.org/10.16965/ijpr.2015.111
- Lupton-Smith A, Fourie K, Mazinyo A, Mokone M, Nxaba S, Morrow B. Measurement of hand grip strength: A cross-sectional study of two dynamometry devices. S Afr J Physiother. 2022 Sep 26;78(1):1768. doi: 10.4102/sajp.v78i1.1768. eCollection 2022.
- Lupowitz LG, Ramus L, Delacour F, Johnson K. TECAR Therapy: A Clinical Commentary on its Evolution, Application, and Future in Rehabilitation. Int J Sports Phys Ther. 2025 Apr 1;20(4):632-640. doi: 10.26603/001c.130909. eCollection 2025.
- Diagne, N., Tonga, M., Seye, M., Sy, A., Mboup, D., Guèye, A., Sakho, M., Lo, P., Seck, L., Fall, M., Ndiaye, M., & Diop, A. (2024). Grip Strength and Carpal Tunnel: What Interest in Management. Journal of Physical Medicine, 5(1). https://doi.org/10.36959/942/347
- Cao, J., Jia, T., Lao, J., Liu, A., & Rui, J. (2022). Evaluation of different physical examination methods for the diagnosis of carpal tunnel syndrome. World Academy of Sciences Journal, 4(5), 33. https://doi.org/10.3892/wasj.2022.168
- Alanazy MH. Clinical and electrophysiological evaluation of carpal tunnel syndrome: approach and pitfalls. Neurosciences (Riyadh). 2017 Jul;22(3):169-180. doi: 10.17712/nsj.2017.3.20160638.
- Albert T, Perrot P, Lecoq FA, Lancien U. Post-burn carpal tunnel syndrome: A systematic review. Hand Surg Rehabil. 2025 Jun;44(3):102134. doi: 10.1016/j.hansur.2025.102134. Epub 2025 Mar 22.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
16 juin 2026
Achèvement primaire (Estimé)
30 octobre 2026
Achèvement de l'étude (Estimé)
1 décembre 2026
Dates d'inscription aux études
Première soumission
16 juin 2026
Première soumission répondant aux critères de contrôle qualité
16 juin 2026
Première publication (Réel)
22 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
25 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
21 juin 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- TECAR on post burn CTS
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .